Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Georgetown University
ClinicalTrials.gov Identifier:
NCT00020748
First received: July 11, 2001
Last updated: March 23, 2011
Last verified: January 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2004
  Primary Completion Date: October 2004 (Final data collection date for primary outcome measure)